TREPROSTINIL TEVA 10 MGML

Pajjiż: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

TREPROSTINIL AS SODIUM

Disponibbli minn:

ABIC MARKETING LTD, ISRAEL

Kodiċi ATC:

B01AC21

Għamla farmaċewtika:

SOLUTION FOR INFUSION

Kompożizzjoni:

TREPROSTINIL AS SODIUM 10 MG/ML

Rotta amministrattiva:

S.C, I.V

Tip ta 'preskrizzjoni:

Not required

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Żona terapewtika:

TREPROSTINIL

Indikazzjonijiet terapewtiċi:

Treprostinil Teva is indicated for the treatment of:- Primary pulmonary arterial hypertension - Pulmonary arterial hypertension associated with connective tissue disorders.- Pulmonary hypertension associated with congenital systemic to pulmonary shunts.

Data ta 'l-awtorizzazzjoni:

2020-11-29